Oramed Pharmaceuticals Inc. (ORMP)
NASDAQ: ORMP · Real-Time Price · USD
2.410
+0.040 (1.69%)
At close: Oct 10, 2025, 4:00 PM EDT
2.410
0.00 (0.00%)
After-hours: Oct 10, 2025, 4:00 PM EDT

Oramed Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20212016 - 2020
Period Ending
Oct '25 Dec '24 Dec '23 Dec '22 Dec '21 Aug '21 2016 - 2020
1009893471544640
Upgrade
Market Cap Growth
4.26%4.69%-80.20%-13.48%-15.00%479.35%
Upgrade
Enterprise Value
1-46-9311444565
Upgrade
Last Close Price
2.372.422.3112.0314.2819.68
Upgrade
PE Ratio
--16.87---
Upgrade
PS Ratio
48.73-69.54174.08200.54236.73
Upgrade
PB Ratio
0.630.670.573.113.265.49
Upgrade
P/TBV Ratio
0.640.670.573.103.275.53
Upgrade
EV/Sales Ratio
0.69--115.15163.83208.87
Upgrade
Debt / Equity Ratio
0.010.000.320.010.000.01
Upgrade
Asset Turnover
0.01-0.010.02-0.03
Upgrade
Quick Ratio
26.6924.973.0527.1019.8514.10
Upgrade
Current Ratio
26.8225.193.0627.3420.0814.27
Upgrade
Return on Equity (ROE)
-14.69%-12.39%3.24%-23.77%--30.78%
Upgrade
Return on Assets (ROA)
-4.94%-4.25%-5.16%-14.95%--17.54%
Upgrade
Return on Capital (ROIC)
-5.16%-4.44%-5.38%-15.90%--20.18%
Upgrade
Earnings Yield
-24.55%-19.54%5.93%-7.77%-6.44%-3.48%
Upgrade
FCF Yield
-16.35%-8.64%-11.32%-6.04%-6.14%-3.37%
Upgrade
Buyback Yield / Dilution
0.21%-0.65%-4.02%-5.08%-30.36%-16.71%
Upgrade
Updated Nov 7, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q